Analysis of patients with SCLC revealed that CTC counts were closely related to clinical factors such as TNM stage, age, and the serum tumor marker neuron-specific enolase; higher CTCs counts were associated with a worse prognosis; and CTCs had a better predictive effect on the prognosis of SCLC [24]. The gene discussed is ENO2; the disease is neoplasm.